Avalon GloboCare Corp. (ALBT) is exploring a strategic partnership with Qi Diagnostics Limited to develop a cannabis breathalyzer using nanosensor technology. The collaboration aims to create a point-of-care device that can detect cannabis use through breath analysis. Avalon’s expertise in regulatory pathways and clinical trials will be instrumental in the development process.